AHN Saint Vincent Hospital holds free public seminar on innovative technology that can reduce the risk of stroke for those with atrial fibrillation
Thursday, September 19, 2019
Patients with atrial fibrillation may be able to reduce their risk of stroke and potentially eliminate their need for blood thinning medication thanks to a groundbreaking new technology available at AHN Saint Vincent Hospital. Information about the technology, called the Watchman Device, will be provided by the hospital at a free public seminar on Monday, Sept 23, at 5:30 p.m. at the Ambassador Conference Center, 7794 Peach St, Erie.
Atrial fibrillation, or AFib, affects the heart’s ability to pump blood normally. This can cause blood to pool in an area of the heart called the left atrial appendage, or LAA. There, blood cells can stick together and form a clot. When a blood clot escapes from the LAA and travels to another part of the body, it can cut off the blood supply to the brain, causing a stroke.
The Watchman Device fits right into the LAA. It’s designed to permanently close it off and keep those blood clots from escaping. WATCHMAN is about the size of a quarter and made from very light and compact materials commonly used in many other medical implants.
Saint Vincent electrophysiologist, Jay Patel, MD and cardiologists Nishant Koradia, MD, and Matthew “Casey” Becker, MD will lead the discussion about the technology and who can benefit from it. .
Doors open at 5:30 pm, presentations begin at 6 p.m. Light refreshments will be served.
Those interested in attending can RSVP to 814-452-7273.